Natural Beauty Bio-Technology Limited (HKG:0157)
Hong Kong
· Delayed Price · Currency is HKD 0.475
0.00 (0.00%)
Apr 29, 2026, 3:55 PM HKT
HKG:0157 Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 538.83 | 353.65 | 336.02 | 335.88 | 487.81 | Upgrade
|
| Revenue Growth (YoY) | 52.36% | 5.25% | 0.04% | -31.14% | 18.78% | Upgrade
|
| Cost of Revenue | 245.49 | 151.32 | 135.67 | 146.75 | 181.81 | Upgrade
|
| Gross Profit | 293.34 | 202.33 | 200.35 | 189.13 | 306 | Upgrade
|
| Selling, General & Admin | 272.15 | 251.39 | 208.17 | 207.82 | 265.23 | Upgrade
|
| Other Operating Expenses | -7.39 | 0.4 | -4.17 | -4.09 | -1.38 | Upgrade
|
| Operating Expenses | 265.98 | 251.66 | 199.93 | 208.45 | 259.87 | Upgrade
|
| Operating Income | 27.36 | -49.33 | 0.42 | -19.32 | 46.13 | Upgrade
|
| Interest Expense | -10.47 | -8.05 | -8.13 | -4.34 | -1.82 | Upgrade
|
| Interest & Investment Income | 1.98 | 0.85 | 1.51 | 1.65 | 2.05 | Upgrade
|
| Earnings From Equity Investments | -0.9 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | 2.43 | - | Upgrade
|
| EBT Excluding Unusual Items | 17.98 | -56.53 | -6.21 | -19.58 | 46.36 | Upgrade
|
| Impairment of Goodwill | - | -24.81 | - | -2.13 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.19 | 0.01 | 0.1 | - | -0.2 | Upgrade
|
| Asset Writedown | -6.36 | -23.88 | -5.76 | -3.8 | 0.53 | Upgrade
|
| Other Unusual Items | - | - | - | 1.97 | 1.77 | Upgrade
|
| Pretax Income | 11.82 | -105.21 | -11.87 | -23.55 | 48.46 | Upgrade
|
| Income Tax Expense | 1.24 | -1.59 | 3.24 | 6.92 | 13.2 | Upgrade
|
| Net Income | 10.58 | -103.62 | -15.11 | -30.47 | 35.26 | Upgrade
|
| Net Income to Common | 10.58 | -103.62 | -15.11 | -30.47 | 35.26 | Upgrade
|
| Net Income Growth | - | - | - | - | 354.55% | Upgrade
|
| Shares Outstanding (Basic) | 2,002 | 2,002 | 2,002 | 2,002 | 2,002 | Upgrade
|
| Shares Outstanding (Diluted) | 2,002 | 2,002 | 2,002 | 2,002 | 2,002 | Upgrade
|
| EPS (Basic) | 0.01 | -0.05 | -0.01 | -0.02 | 0.02 | Upgrade
|
| EPS (Diluted) | 0.01 | -0.05 | -0.01 | -0.02 | 0.02 | Upgrade
|
| EPS Growth | - | - | - | - | 354.65% | Upgrade
|
| Free Cash Flow | -83.76 | -54.96 | -47.39 | -32.75 | 6.5 | Upgrade
|
| Free Cash Flow Per Share | -0.04 | -0.03 | -0.02 | -0.02 | 0.00 | Upgrade
|
| Dividend Per Share | - | - | - | - | 0.003 | Upgrade
|
| Gross Margin | 54.44% | 57.21% | 59.62% | 56.31% | 62.73% | Upgrade
|
| Operating Margin | 5.08% | -13.95% | 0.12% | -5.75% | 9.46% | Upgrade
|
| Profit Margin | 1.96% | -29.30% | -4.50% | -9.07% | 7.23% | Upgrade
|
| Free Cash Flow Margin | -15.54% | -15.54% | -14.10% | -9.75% | 1.33% | Upgrade
|
| EBITDA | 57.78 | -23.02 | 21.4 | 4.61 | 72.04 | Upgrade
|
| EBITDA Margin | 10.72% | -6.51% | 6.37% | 1.37% | 14.77% | Upgrade
|
| D&A For EBITDA | 30.42 | 26.31 | 20.98 | 23.94 | 25.91 | Upgrade
|
| EBIT | 27.36 | -49.33 | 0.42 | -19.32 | 46.13 | Upgrade
|
| EBIT Margin | 5.08% | -13.95% | 0.12% | -5.75% | 9.46% | Upgrade
|
| Effective Tax Rate | 10.45% | - | - | - | 27.23% | Upgrade
|
| Advertising Expenses | 22.58 | 32.53 | 39.22 | 13.29 | 45.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.